Vera Therapeutics (VERA) Non Operating Income (2020 - 2026)
Vera Therapeutics' (VERA) quarterly Non Operating Income came in at $4.1 million in Q1 2026, down 25.45% YoY from $5.5 million in Q1 2025, and up 31.83% on a QoQ basis from $3.1 million in Q4 2025.
Vera Therapeutics (VERA) Non Operating Income (2020 - 2026) Analysis & Trends
Vera Therapeutics (VERA) has 7 years of Non Operating Income data on file, last reported at $4.1 million in Q1 2026.
- Quarterly Non Operating Income fell 25.45% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.5 million (down 18.74% YoY) and the FY2025 annual result came in at $15.9 million, up 5.56% from the prior year.
- Non Operating Income grew to $4.1 million in Q1 2026, from $3.1 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $5.5 million in Q1 2025 to a low of -$64000.0 in Q1 2022.
- A 5-year average of $2.5 million and a median of $2.7 million in 2024 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income sank 3300.0% — and 2023, when it jumped 1957.81%.
- Tracing VERA's Non Operating Income over 5 years: stood at $1.1 million in 2022, then grew by 20.21% to $1.4 million in 2023, then jumped by 299.56% to $5.5 million in 2024, then sank by 43.35% to $3.1 million in 2025, then jumped by 31.83% to $4.1 million in 2026.
- The last three Non Operating Income figures came in at $4.1 million (Q1 2026), $3.1 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - | 3.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.02 Mn |
| Mar 31, 2026 | 4.10 Mn |
| Dec 31, 2025 | 3.11 Mn |
| Sep 30, 2025 | 3.64 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | 5.50 Mn |
| Dec 31, 2024 | 5.49 Mn |
| Sep 30, 2024 | 3.17 Mn |
| Jun 30, 2024 | 3.64 Mn |
| Mar 31, 2024 | 2.73 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 1.81 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 565,000.00 |
| Jun 30, 2022 | 204,000.00 |
| Mar 31, 2022 | -64,000.00 |
| Dec 31, 2021 | -261,000.00 |
| Sep 30, 2021 | -359,000.00 |